Rankings
▼
Calendar
IART
Integra LifeSciences Holdings Corporation
$747M
Q3 2018 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$366M
+31.2% YoY
Gross Profit
$223M
60.8% margin
Operating Income
$24M
6.5% margin
Net Income
$13M
3.6% margin
EPS (Diluted)
$0.15
QoQ Revenue Growth
-0.1%
Cash Flow
Operating Cash Flow
$79M
Free Cash Flow
$63M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$3.2B
Total Liabilities
$1.4B
Stockholders' Equity
$1.4B
Cash & Equivalents
$206M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$366M
$279M
+31.2%
Gross Profit
$223M
$177M
+25.7%
Operating Income
$24M
$11M
+122.5%
Net Income
$13M
$3M
+320.9%
Revenue Segments
Codman Specialty Surgical
$239M
65%
Orthopedics and Tissue Technologies
$127M
35%
Geographic Segments
UNITED STATES
$261M
71%
Europe
$47M
13%
Asia Pacific
$37M
10%
Rest Of World
$20M
6%
← FY 2018
All Quarters
Q4 2018 →
IART Q3 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena